119 related articles for article (PubMed ID: 16786763)
1. [The role of genetic polymorphisms within tumor necrosis factor promoter gene in non-Hodgkin's lymphomas].
Juszczyński P; Kalinka E; Woszczek G; Borowiec M; Robak T; Kowalski ML; Biliński P; Coiffiers B; Salles G; Warzocha K
Przegl Lek; 2005; 62(12):1417-21. PubMed ID: 16786763
[TBL] [Abstract][Full Text] [Related]
2. [The role of HLA DRB1 genetic polymorphisms in non-Hodgkin's lymphomas].
Kalinka E; Juszczyński P; Woszczek G; Borowiec M; Robak T; Kowalski ML; Biliński P; Coiffier B; Salles G; Warzocha K
Przegl Lek; 2005; 62(12):1422-6. PubMed ID: 16786764
[TBL] [Abstract][Full Text] [Related]
3. Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome.
Nowak J; Kalinka-Warzocha E; Juszczyński P; Mika-Witkowska R; Zajko M; Graczyk-Pol E; Coiffier B; Salles G; Warzocha K
Tissue Antigens; 2008 Jan; 71(1):16-26. PubMed ID: 17971052
[TBL] [Abstract][Full Text] [Related]
4. Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma.
Nowak J; Kalinka-Warzocha E; Juszczynski P; Bilinski P; Mika-Witkowska R; Zajko M; Bienvenu J; Coiffier B; Salles G; Warzocha K
Genes Chromosomes Cancer; 2007 May; 46(5):500-7. PubMed ID: 17311253
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin's lymphomas.
Bel Hadj Jrad B; Chatti A; Laatiri A; Ahmed SB; Romdhane A; Ajimi S; Chouchane L
Eur J Haematol; 2007 Feb; 78(2):117-22. PubMed ID: 17087739
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95.
Seidemann K; Zimmermann M; Book M; Meyer U; Burkhardt B; Welte K; Reiter A; Stanulla M
J Clin Oncol; 2005 Nov; 23(33):8414-21. PubMed ID: 16293872
[TBL] [Abstract][Full Text] [Related]
7. Alleles -308A and -1031C in the TNF-alpha gene promoter do not increase the risk but associated with circulating levels of TNF-alpha and clinical features of vivax malaria in Indian patients.
Sohail M; Kaul A; Bali P; Raziuddin M; Singh MP; Singh OP; Dash AP; Adak T
Mol Immunol; 2008 Mar; 45(6):1682-92. PubMed ID: 17996942
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor alpha promoter polymorphism associated with increased susceptibility to secondary hemophagocytic lymphohistiocytosis in the Korean population.
Chang YH; Lee DS; Jo HS; Cho SI; Yoon HJ; Shin S; Yoon JH; Kim HY; Hong YJ; Hong SI; Cho HI
Cytokine; 2006 Oct; 36(1-2):45-50. PubMed ID: 17166738
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome.
Juszczynski P; Kalinka E; Bienvenu J; Woszczek G; Borowiec M; Robak T; Kowalski M; Lech-Maranda E; Baseggio L; Coiffier B; Salles G; Warzocha K
Blood; 2002 Oct; 100(8):3037-40. PubMed ID: 12351419
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-10 gene polymorphisms influence the clinical course of non-Hodgkin's lymphoma.
Bogunia-Kubik K; Mazur G; Wróbel T; Kuliczkowski K; Lange A
Tissue Antigens; 2008 Feb; 71(2):146-50. PubMed ID: 18201362
[TBL] [Abstract][Full Text] [Related]
11. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
Cheong JY; Cho SW; Hwang IL; Yoon SK; Lee JH; Park CS; Lee JE; Hahm KB; Kim JH
J Gastroenterol Hepatol; 2006 Jul; 21(7):1163-9. PubMed ID: 16824070
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta1 gene polymorphisms influence the course of the disease in non-Hodgkin's lymphoma patients.
Mazur G; Bogunia-Kubik K; Wrobel T; Kuliczkowski K; Lange A
Cytokine; 2006 Feb; 33(3):145-9. PubMed ID: 16524740
[TBL] [Abstract][Full Text] [Related]
13. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.
Kube D; Hua TD; von Bonin F; Schoof N; Zeynalova S; Klöss M; Gocht D; Potthoff B; Tzvetkov M; Brockmöller J; Löffler M; Pfreundschuh M; Trümper L
Clin Cancer Res; 2008 Jun; 14(12):3777-84. PubMed ID: 18559596
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet's disease.
Kamoun M; Chelbi H; Houman MH; Lacheb J; Hamzaoui K
Hum Immunol; 2007 Mar; 68(3):201-5. PubMed ID: 17349875
[TBL] [Abstract][Full Text] [Related]
15. Associations of promoter region polymorphisms in the tumour necrosis factor-alpha gene and early-onset psoriasis vulgaris in a northern Polish population.
Nedoszytko B; Szczerkowska-Dobosz A; Zabłotna M; Gleń J; Rebała K; Roszkiewicz J
Br J Dermatol; 2007 Jul; 157(1):165-7. PubMed ID: 17553030
[TBL] [Abstract][Full Text] [Related]
16. Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma.
Goto N; Tsurumi H; Takemura M; Hara T; Sawada M; Kasahara S; Kanemura N; Yamada T; Shimizu M; Takahashi T; Tomita E; Seishima M; Takami T; Moriwaki H
Eur J Haematol; 2006 Sep; 77(3):217-25. PubMed ID: 16856931
[TBL] [Abstract][Full Text] [Related]
17. [Serum tumor necrosis factor-alpha levels in non-Hodgkin's lymphoma patients and its relationship to prognosis].
Li D; Li G; Wang B
Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):293-6. PubMed ID: 11038763
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha-308 and Lymphotoxin alpha+252 genetic polymorphisms and the susceptibility to non-Hodgkin lymphoma in Egypt.
Ibrahim A; Abdel Rahman H; Khorshied M; Sami R; Nasr N; Khorshid O
Leuk Res; 2012 Jun; 36(6):694-8. PubMed ID: 22177457
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population.
Jiménez-Morales S; Velázquez-Cruz R; Ramírez-Bello J; Bonilla-González E; Romero-Hidalgo S; Escamilla-Guerrero G; Cuevas F; Espinosa-Rosales F; Martínez-Aguilar NE; Gómez-Vera J; Baca V; Orozco L
Hum Immunol; 2009 Apr; 70(4):251-6. PubMed ID: 19480843
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.
Warzocha K; Salles G; Bienvenu J; Bastion Y; Dumontet C; Renard N; Neidhardt-Berard EM; Coiffier B
J Clin Oncol; 1997 Feb; 15(2):499-508. PubMed ID: 9053471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
